Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	348.89	399.27	276.47	869.19	397.66	683.29
Short-Term Investments	1,857	1,932	1,710	1,246	1,495	1,816
Cash & Cash Equivalents	2,206	2,331	1,987	2,115	1,892	2,500
Cash Growth	-5.99%	17.33%	-6.06%	11.76%	-24.29%	19.94%
Receivables	5.14	97.78	25.54	61.9	76.2	63.03
Inventory	30.26	28.43	22.03	24.81	21.97	18.18
Other Current Assets	174.06	184.45	168.25	143.37	140.16	139.84
Total Current Assets	2,416	2,642	2,203	2,345	2,131	2,721
Property, Plant & Equipment	242.23	242.94	255.84	196.04	181.08	153.65
Goodwill and Intangibles	0	0	0	0	27.94	25.67
Other Long-Term Assets	106.03	105.28	75.34	70.6	50.03	333.19
Total Long-Term Assets	348.25	348.22	331.18	266.64	259.05	512.52
Total Assets	2,764	2,990	2,534	2,612	2,390	3,233
Accounts Payable	13.08	26.03	17.92	11.9	17.2	16.07
Deferred Revenue	345.49	392.31	378.35	449.59	532.42	608.33
Current Debt	44.38	44.33	0	0	316.11	2.03
Other Current Liabilities	-75.31	-14.58	-84.71	-220.95	-266.83	-353.42
Total Current Liabilities	327.65	448.09	311.56	240.55	598.9	273.01
Long-Term Debt	1,400	1,400	1,362	1,248	623.53	785.5
Other Long-Term Liabilities	740.16	754.92	287.77	351.88	424.05	490.06
Total Long-Term Liabilities	2,140	2,155	1,649	1,599	1,048	1,276
Total Liabilities	2,467	2,603	1,961	1,840	1,646	1,549
Total Debt	1,444	1,445	1,362	1,248	939.64	787.53
Debt Growth	6.07%	6.10%	9.15%	32.77%	19.32%	21.77%
Retained Earnings	-1,938.71	-1,795.91	-1,429.63	-1,159.9	-1,131.31	-707.53
Comprehensive Income	-34.96	-32.65	-57.48	-32.67	-21.07	-25.29
Shareholders' Equity	296.52	386.69	572.89	771.74	743.28	1,471
Net Cash / Debt	762.23	886.49	625.21	867.45	952.74	1,712
Net Cash / Debt Growth	-22.65%	41.79%	-27.93%	-8.95%	-44.35%	19.11%
Net Cash Per Share	5.24	6.19	4.41	6.15	6.82	11.18
Working Capital	2,088	2,194	1,891	2,104	1,532	2,448
Book Value Per Share	2.04	2.70	4.04	5.47	5.32	10.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).